NSCLC tissues; matched paracancerous tissues; adjacent normal tissues; tumor tissues
NCI-H1299; NCI-H1975; A549; PC9; EBAS-2B
cell line-derived xenograft
proliferation (promotes); migration (promotes); invasion (promotes); ceRNA regulation (promotes); other pathway/process (promotes)
RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Transfection; CCK8; EdU Staining; Colony Formation Assay; Transwell Assay; Wound Healing Assay; IHC (Immunohistochemistry); IF (Immunofluorescence); Western Blot; In Vivo Animal Model; Bioinformatics Analysis
Potential aid for improvement of NSCLC treatments.
circ_0007841 is up-regulated in NSCLC tissues and cell lines and functions as an oncogenic circRNA. Mechanistically, it sponges miR-199a-5p to increase SphK2 expression, thereby promoting NSCLC cell proliferation, migration, invasion, adhesion-related protein changes, and xenograft tumor growth.
0.8443
Circular RNA circ_0007841 participates in progression of nonsmall cell lung cancer via miR-199a-5p/SphK2 axis.
combined biological and clinical study